Ellie Brandon
Papers
1
Total Citations
138
H-Index
1
About
Dr. Ellie Brandon is a pioneering surgical oncologist whose research focuses on advancing minimally invasive techniques for liver cancer treatment, with a particular emphasis on robotic surgery for hepatocellular carcinoma (HCC). Her landmark 2022 study, "Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma," has garnered 138 citations, addressing a critical gap in the literature by providing long-term oncologic outcomes from a Western high-volume center. This work directly tackles the contentious debate surrounding robotic liver resection (RLR), demonstrating its safety and efficacy while offering robust comparative data against traditional open approaches. Dr. Brandon’s contributions are instrumental in shaping evidence-based guidelines for HCC management, bridging the divide between technological innovation and clinical practice. Her research has profound implications for improving patient recovery and survival, solidifying her reputation as a leader in surgical oncology. With a growing citation impact, Dr. Brandon continues to influence the trajectory of robotic surgery, inspiring both clinical adoption and further investigation into its long-term benefits.
Research Focus
Key Achievements
Top Papers
- 1